Skip to main content
TipRanks
Go Ultimate75% OFF

Biocept (BIOCQ) Stock Statistics & Valuation Metrics

1,241 Followers

Total Valuation

Biocept has a market cap or net worth of $525.00. The enterprise value is $6.21M.

Market Cap
$525.00
Enterprise Value
$6.21M

Share Statistics

Biocept has 2,626,026 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
2,626,026
Owned by Insiders
―
Owned by Institutions
5.21%

Financial Efficiency

Biocept’s return on equity (ROE) is -3.62 and return on invested capital (ROIC) is -117.56%.

Return on Equity (ROE)
-3.62
Return on Assets (ROA)
-1.04
Return on Invested Capital (ROIC)
-117.56%
Return on Capital Employed (ROCE)
-1.26
Revenue Per Employee
517.16K
Profits Per Employee
-641.74K
Employee Count
50
Asset Turnover
0.84
Inventory Turnover
37.57

Valuation Ratios

The current PE Ratio of Biocept is -0.00. Biocept’s PEG ratio is 0.00.

PE Ratio
-0.00
PS Ratio
0.00
PB Ratio
0.00
Price to FCF
-0.00
Price to Operating Cash Flow
-0.00
PEG Ratio
0.00

Income Statement

In the last 12 months, Biocept had revenue of 25.86M and earned -32.09M in profits. Earnings per share was -56.78.

Revenue
25.86M
Gross Profit
-2.58M
Operating Income
-31.98M
Pretax Income
-32.21M
Net Income
-32.09M
EBITDA
-30.24M
Earnings Per Share (EPS)
-56.78

Cash Flow

In the last 12 months, operating cash flow was -17.60M and capital expenditures -680,000, giving a free cash flow of -18.28M billion.

Operating Cash Flow
-17.60M
Free Cash Flow
-18.28M
Free Cash Flow per Share
-24.94

Dividends & Yields

Biocept pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-2684952.38%
Earnings Yield
-28389193.93%

Stock Price Statistics

Beta
97.85
52-Week Price Change
-52.00%
50-Day Moving Average
0.04
200-Day Moving Average
0.04
Relative Strength Index (RSI)
―
Average Volume (3m)
―

Important Dates

Biocept upcoming earnings date is ―, TBA (Not Confirmed).

Last Earnings Date
Aug 12, 2024
Next Earnings Date
―
Ex-Dividend Date
―

Financial Position

Biocept as a current ratio of 2.97, with Debt / Equity ratio of 136.67%

Current Ratio
2.97
Quick Ratio
2.83
Debt to Market Cap
0.04
Net Debt to EBITDA
0.03
Interest Coverage Ratio
-101.21

Taxes

In the past 12 months, Biocept has paid -125.00K in taxes.

Income Tax
-125.00K
Effective Tax Rate
0.00

Enterprise Valuation

Biocept EV to EBITDA ratio is 0.03, with an EV/FCF ratio of 0.06.

EV to Sales
-0.03
EV to EBITDA
0.03
EV to Free Cash Flow
0.06
EV to Operating Cash Flow
0.06

Balance Sheet

Biocept has $6.63M in cash and marketable securities with $11.59M in debt, giving a net cash position of -$4.96M billion.

Cash & Marketable Securities
$6.63M
Total Debt
$11.59M
Net Cash
-$4.96M
Net Cash Per Share
-$1.89
Tangible Book Value Per Share
$0.28

Margins

Gross margin is -9.99%, with operating margin of -123.69%, and net profit margin of -124.09%.

Gross Margin
-9.99%
Operating Margin
-123.69%
Pretax Margin
-124.57%
Net Profit Margin
-124.09%
EBITDA Margin
-116.95%
EBIT Margin
-123.35%